There was a higher incidence of myocardial ischemia in the levosimendan group at @ days than in the placebo group ( @ vs. @ % , HR @ , p = @ ) , but between @ and @ days , it was significantly lower in the levosimendan group than in the placebo group ( @ vs. @ % , HR @ , p = @ ) .